Drug Name: Ivermectin + Albendazole | Drug Class: Antiparasitic Combination | Brand Reference: Albendazole + Ivermectin (WHO MDA kit); IVA combination (Indian generics) | Indication: Lymphatic filariasis mass drug administration (MDA), mixed helminth infections, strongyloidiasis with co-infections | Standard Dose: WHO MDA standard: single annual dose of ivermectin 200mcg/kg + albendazole 400mg
The ivermectin 6mg + albendazole 400mg combination is the WHO-recommended annual single-dose treatment for lymphatic filariasis (elephantiasis) mass drug administration programmes. Ivermectin eliminates microfilariae and ectoparasites while albendazole targets intestinal worms, providing dual parasite control in a single dose. This combination is used across over 50 countries in WHO tropical disease elimination programmes.
Ivermectin-Albendazole 6mg-400mg contains Ivermectin + Albendazole, a antiparasitic combination. It is indicated for lymphatic filariasis mass drug administration (mda), mixed helminth infections, strongyloidiasis with co-infections. WHO recommended combination for lymphatic filariasis elimination; 2017 Cochrane review confirmed additive efficacy.
| Attribute | Details |
|---|---|
| Generic Name | Ivermectin + Albendazole |
| Drug Class | Antiparasitic Combination |
| Brand Reference | Albendazole + Ivermectin (WHO MDA kit); IVA combination (Indian generics) |
| Primary Indication | Lymphatic filariasis mass drug administration (MDA), mixed helminth infections, strongyloidiasis with co-infections |
| Standard Dose | WHO MDA standard: single annual dose of ivermectin 200mcg/kg + albendazole 400mg |
| Dosage Form | Tablet combination |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Evidence Base | WHO recommended combination for lymphatic filariasis elimination; 2017 Cochrane review confirmed additive efficacy |
Ivermectin: disrupts chloride channels in parasites causing paralysis. Albendazole: inhibits tubulin polymerisation blocking worm glucose absorption. This mechanism of action makes Ivermectin + Albendazole effective against lymphatic filariasis mass drug administration (mda), mixed helminth infections, strongyloidiasis with co-infections.
The combination provides complementary anti-parasitic coverage. Ivermectin kills microfilariae (filarial larvae) and ectoparasites like scabies and lice. Albendazole treats intestinal nematodes that often co-infect patients in tropical regions. Together, they reduce total parasitic burden more effectively than either drug alone, which is why WHO uses this pairing in mass drug administration.
Yes — the WHO has administered this combination to hundreds of millions of people in lymphatic filariasis elimination programmes with an excellent safety record. Drug-drug interactions are minimal. The most common reactions are from dying parasites (fever, rash) rather than drug toxicity. Pregnant women in the first trimester are excluded from MDA programmes.
WHO’s Global Programme to Eliminate Lymphatic Filariasis (GPELF) delivers annual single doses of ivermectin + albendazole (in non-onchocerciasis regions) to entire at-risk populations. The programme has treated over 8 billion doses since 2000 and has eliminated filariasis as a public health problem in 16 countries.
Yes — beyond the WHO filariasis programme, this combination treats mixed helminth infections common in tropical regions where patients may simultaneously have intestinal worms and filarial infections. A single combined dose is more practical and cost-effective than separate treatments.
Most side effects are reactions to dying parasites: fever, headache, myalgia, rash, and mild oedema. Direct drug side effects include nausea, dizziness, and abdominal discomfort. Serious adverse effects are rare at recommended doses. The combination is well-tolerated across all age groups in WHO programmes.
Store at room temperature (15–30°C) away from direct sunlight, heat, and moisture. Keep out of reach of children and pets. Do not use after the expiry date printed on the packaging.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.